avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfx
|
ENSMUSG00000079509.11 | Zfx |
Zfp711
|
ENSMUSG00000025529.15 | Zfp711 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zfx | mm39_v1_chrX_-_93166992_93167018 | 0.90 | 3.7e-14 | Click! |
Zfp711 | mm39_v1_chrX_+_111510223_111510223 | 0.62 | 5.3e-05 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 24.2 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
4.0 | 11.9 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
3.9 | 11.7 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
3.5 | 17.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.6 | 7.7 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
2.3 | 6.9 | GO:0034117 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
2.2 | 8.9 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.2 | 8.9 | GO:0051673 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) membrane disruption in other organism(GO:0051673) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
2.2 | 6.5 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
2.1 | 10.3 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
2.1 | 8.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.9 | 5.8 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
1.9 | 11.3 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
1.9 | 22.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.8 | 5.4 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.7 | 6.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.6 | 4.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.6 | 6.4 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.5 | 4.6 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
1.5 | 7.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.5 | 3.0 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
1.5 | 17.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.5 | 3.0 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
1.5 | 10.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
1.4 | 4.3 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
1.4 | 7.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.4 | 4.2 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
1.4 | 7.0 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
1.4 | 2.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
1.4 | 5.5 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
1.4 | 5.4 | GO:0046898 | response to cycloheximide(GO:0046898) |
1.3 | 4.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.3 | 13.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.3 | 4.0 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
1.3 | 5.2 | GO:0003290 | atrial septum secundum morphogenesis(GO:0003290) |
1.3 | 1.3 | GO:1990535 | neuron projection maintenance(GO:1990535) |
1.3 | 10.3 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.3 | 6.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
1.3 | 3.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.3 | 1.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
1.3 | 5.0 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.2 | 8.7 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
1.2 | 10.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.2 | 3.7 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
1.2 | 8.5 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
1.2 | 5.9 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
1.2 | 4.6 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
1.2 | 4.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.2 | 3.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.1 | 3.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.1 | 6.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.1 | 4.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.1 | 4.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.1 | 5.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.1 | 6.4 | GO:0042117 | monocyte activation(GO:0042117) |
1.0 | 5.2 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
1.0 | 7.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.0 | 3.1 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
1.0 | 12.2 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
1.0 | 5.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.0 | 3.0 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
1.0 | 5.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.0 | 3.0 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
1.0 | 10.8 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
1.0 | 1.0 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
1.0 | 3.9 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.0 | 7.7 | GO:0044838 | cell quiescence(GO:0044838) |
0.9 | 2.8 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.9 | 2.8 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
0.9 | 3.7 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
0.9 | 2.8 | GO:1904172 | positive regulation of bleb assembly(GO:1904172) |
0.9 | 9.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.9 | 3.7 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.9 | 3.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.9 | 3.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.9 | 4.5 | GO:1904170 | regulation of bleb assembly(GO:1904170) negative regulation of bleb assembly(GO:1904171) |
0.9 | 8.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 2.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.9 | 3.6 | GO:0010286 | heat acclimation(GO:0010286) |
0.9 | 2.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.9 | 0.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.9 | 1.8 | GO:0014737 | positive regulation of muscle atrophy(GO:0014737) |
0.9 | 2.6 | GO:0036491 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.9 | 5.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.9 | 1.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.9 | 2.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.9 | 4.3 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.9 | 2.6 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.9 | 4.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.9 | 4.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.9 | 5.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.9 | 3.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.9 | 2.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.9 | 8.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.8 | 2.5 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
0.8 | 3.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.8 | 11.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.8 | 5.0 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.8 | 3.3 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
0.8 | 5.8 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.8 | 0.8 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.8 | 4.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 5.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 2.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.8 | 9.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.8 | 0.8 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.8 | 3.3 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.8 | 8.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.8 | 4.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.8 | 1.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.8 | 1.6 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.8 | 3.9 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.8 | 29.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.8 | 0.8 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.8 | 2.3 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.8 | 2.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.8 | 3.1 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.8 | 1.5 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.7 | 2.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.7 | 3.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.7 | 3.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.7 | 2.2 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.7 | 2.2 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.7 | 2.2 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.7 | 0.7 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.7 | 9.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.7 | 7.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.7 | 3.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 5.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 15.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.7 | 10.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.7 | 5.0 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.7 | 9.9 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.7 | 1.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.7 | 2.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.7 | 3.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.7 | 2.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.7 | 5.5 | GO:0032796 | uropod organization(GO:0032796) |
0.7 | 2.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 1.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.7 | 5.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.7 | 2.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.7 | 5.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.7 | 11.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.7 | 1.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 2.7 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.7 | 0.7 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
0.7 | 2.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.7 | 4.7 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.7 | 4.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.7 | 10.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.7 | 3.3 | GO:0051595 | response to methylglyoxal(GO:0051595) |
0.7 | 8.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.7 | 4.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.7 | 2.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.7 | 6.6 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.7 | 2.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.7 | 3.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.7 | 5.2 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.6 | 4.5 | GO:0090234 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
0.6 | 1.9 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.6 | 0.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.6 | 1.9 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.6 | 1.3 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.6 | 5.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 0.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 5.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.6 | 2.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.6 | 9.4 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.6 | 3.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.6 | 5.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.6 | 4.4 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.6 | 7.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.6 | 5.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.6 | 1.9 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.6 | 2.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.6 | 2.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 6.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.6 | 9.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.6 | 1.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 0.6 | GO:1901003 | negative regulation of fermentation(GO:1901003) |
0.6 | 4.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.6 | 1.2 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.6 | 0.6 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.6 | 3.6 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.6 | 1.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.6 | 1.8 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.6 | 1.2 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.6 | 1.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.6 | 0.6 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 1.7 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.6 | 4.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 1.7 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.6 | 1.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.6 | 1.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.6 | 2.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.6 | 11.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.6 | 0.6 | GO:0045472 | response to ether(GO:0045472) |
0.6 | 1.7 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.6 | 3.4 | GO:0015871 | choline transport(GO:0015871) |
0.6 | 4.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.6 | 1.1 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.6 | 1.7 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.6 | 0.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.5 | 3.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.5 | 1.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.5 | 6.6 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.5 | 7.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.5 | 18.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.5 | 2.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.5 | 1.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.5 | 2.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 2.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.5 | 1.6 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.5 | 17.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.5 | 2.1 | GO:0015904 | tetracycline transport(GO:0015904) |
0.5 | 1.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.5 | 3.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.5 | 5.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 1.6 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.5 | 6.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.5 | 1.6 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.5 | 4.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.5 | 2.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.5 | 1.6 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.5 | 2.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 2.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.5 | 2.1 | GO:0001743 | optic placode formation(GO:0001743) |
0.5 | 4.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 3.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.5 | 2.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.5 | 3.6 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.5 | 2.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.5 | 12.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.5 | 2.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 4.0 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.5 | 5.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.5 | 1.5 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
0.5 | 1.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.5 | 2.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.5 | 3.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 3.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.5 | 1.0 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.5 | 3.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.5 | 4.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 1.5 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.5 | 1.5 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.5 | 0.5 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.5 | 1.5 | GO:0046032 | ADP catabolic process(GO:0046032) |
0.5 | 5.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 1.5 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.5 | 5.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.5 | 1.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.5 | 1.5 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.5 | 1.0 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.5 | 3.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.5 | 1.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.5 | 1.4 | GO:0035037 | sperm entry(GO:0035037) |
0.5 | 1.0 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.5 | 6.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.5 | 1.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.5 | 7.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.5 | 0.9 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.5 | 2.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.5 | 4.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.5 | 2.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 3.3 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 3.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.5 | 2.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.5 | 0.9 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.5 | 2.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.5 | 1.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.5 | 2.8 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 1.4 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.5 | 2.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 5.0 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.5 | 3.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.5 | 2.7 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.5 | 0.9 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
0.5 | 1.4 | GO:1903413 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
0.5 | 1.4 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
0.4 | 2.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.4 | 0.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 2.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 1.3 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.4 | 3.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 1.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.4 | 1.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.4 | 1.3 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.4 | 7.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 1.8 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.4 | 4.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 2.2 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 6.6 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.4 | 3.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.4 | 1.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 1.7 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 0.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.4 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 4.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 1.7 | GO:0006116 | NADH oxidation(GO:0006116) |
0.4 | 4.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 3.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 1.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 6.8 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.4 | 1.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 10.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.4 | 1.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 0.8 | GO:0009644 | response to high light intensity(GO:0009644) |
0.4 | 2.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 3.0 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.4 | 0.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 1.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 1.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 1.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 2.5 | GO:0030421 | defecation(GO:0030421) |
0.4 | 3.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 2.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 3.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.4 | 6.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 0.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.4 | 4.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 0.8 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.4 | 2.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 1.2 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.4 | 1.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.4 | 2.0 | GO:0060356 | leucine import(GO:0060356) |
0.4 | 0.8 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.4 | 0.8 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.4 | 0.8 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.4 | 0.8 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.4 | 1.2 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.4 | 9.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.4 | 1.2 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.4 | 2.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 7.8 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.4 | 1.2 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.4 | 1.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 1.6 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.4 | 14.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.4 | 1.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 1.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.4 | 0.4 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
0.4 | 1.9 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.4 | 1.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.4 | 1.5 | GO:0016240 | autophagosome docking(GO:0016240) |
0.4 | 3.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.4 | 5.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 2.7 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.4 | 1.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.4 | 2.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 4.9 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.4 | 12.8 | GO:0048821 | erythrocyte development(GO:0048821) |
0.4 | 6.4 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.4 | 29.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.4 | 4.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.4 | 1.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.4 | 3.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.4 | 1.1 | GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299) |
0.4 | 2.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.4 | 1.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 2.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.4 | 3.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 2.5 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.4 | 1.1 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.4 | 2.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.4 | 1.1 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.4 | 7.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 2.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 1.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 3.1 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 2.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 3.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 1.7 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.3 | 1.0 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.3 | 3.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 9.0 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.3 | 10.0 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.3 | 2.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 1.0 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.3 | 2.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.3 | 2.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 4.4 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.3 | 4.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 5.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 1.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.3 | 4.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 3.4 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.3 | 1.0 | GO:0001762 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
0.3 | 0.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 0.7 | GO:0015675 | nickel cation transport(GO:0015675) |
0.3 | 1.0 | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.3 | 0.3 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 1.0 | GO:2000566 | positive regulation of protein K63-linked ubiquitination(GO:1902523) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.3 | 2.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 0.3 | GO:2000847 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 1.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.3 | 1.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) positive regulation of muscle hyperplasia(GO:0014739) muscle hyperplasia(GO:0014900) |
0.3 | 0.3 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.3 | 1.6 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 0.6 | GO:0072716 | response to actinomycin D(GO:0072716) |
0.3 | 1.6 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
0.3 | 3.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.3 | 1.0 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.3 | 1.6 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.3 | 1.9 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 1.0 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
0.3 | 0.6 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.3 | 4.8 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 2.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 1.0 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.3 | 7.6 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.3 | 1.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 1.3 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.3 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 5.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.3 | 1.6 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 5.0 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 5.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 1.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 0.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 2.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.3 | 2.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 1.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.5 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 1.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 0.9 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 0.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.3 | 1.2 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 0.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 3.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.3 | 0.9 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.3 | 1.5 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 2.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 5.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 5.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 1.5 | GO:1900150 | regulation of defense response to fungus(GO:1900150) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.3 | 7.9 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.3 | 1.2 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.3 | 0.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 7.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.3 | 1.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 11.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 2.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 11.8 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.3 | 0.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 2.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 0.9 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.3 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 0.3 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.3 | 0.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 0.9 | GO:0031104 | dendrite regeneration(GO:0031104) |
0.3 | 9.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 0.6 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.3 | 1.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 1.1 | GO:0003192 | mitral valve formation(GO:0003192) |
0.3 | 2.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 1.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.3 | 1.1 | GO:1904884 | establishment of RNA localization to telomere(GO:0097694) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.3 | 0.6 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.3 | 1.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 1.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 1.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.3 | 0.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 1.1 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.3 | 0.8 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 2.8 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.3 | 15.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 1.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.3 | 2.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 1.4 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 3.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 0.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 1.4 | GO:2000407 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) |
0.3 | 1.1 | GO:0006168 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.3 | 2.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 4.8 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.3 | 1.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.3 | 2.9 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.3 | 1.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.1 | GO:0061215 | regulation of pronephros size(GO:0035565) hepatoblast differentiation(GO:0061017) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
0.3 | 1.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.3 | 1.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 3.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 5.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 2.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 1.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 0.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.3 | 4.1 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.3 | 3.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 0.5 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.3 | 8.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 12.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.3 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 2.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.3 | 0.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 0.8 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.3 | 1.0 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.3 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 3.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 4.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 2.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 2.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 4.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 1.0 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
0.2 | 0.2 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.2 | 1.7 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 8.2 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.2 | 0.7 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 0.5 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 2.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 1.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.2 | 0.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.2 | 0.5 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.2 | 0.7 | GO:0099541 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
0.2 | 4.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.5 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.2 | 2.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.2 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 0.5 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.2 | 1.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.5 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.2 | 0.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 0.9 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.2 | 8.9 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 0.2 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.2 | 0.5 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 1.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 3.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.2 | 15.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.2 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.2 | 2.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 1.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 5.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 0.9 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.2 | 0.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 1.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 1.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 2.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.2 | 4.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 1.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 3.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.9 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.2 | 2.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 1.6 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 3.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 4.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 2.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.2 | 1.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 0.4 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 7.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 2.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 1.3 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 0.7 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.2 | 2.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 2.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 1.3 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.3 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.2 | 2.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 5.4 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 0.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 0.4 | GO:0017126 | nucleologenesis(GO:0017126) |
0.2 | 0.9 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 10.9 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.2 | 1.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.9 | GO:0033366 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.2 | 0.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 1.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 1.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 1.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.2 | 0.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.8 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.2 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 11.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 1.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.6 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.2 | 1.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.8 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.2 | 2.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.4 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.4 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.6 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.2 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 1.6 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.6 | GO:2001280 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 2.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 5.1 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.6 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.2 | 0.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 1.0 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.2 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 2.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.4 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 10.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 2.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 3.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 1.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 1.0 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 0.8 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 1.9 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.2 | 0.6 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.2 | 0.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 5.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 4.7 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 1.1 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 0.2 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.2 | 0.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 5.3 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.2 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 64.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 2.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 4.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 8.6 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 2.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.6 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 1.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.5 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 8.4 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 6.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.5 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.2 | 2.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.2 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 0.7 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.2 | 0.4 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
0.2 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 1.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.2 | 1.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 2.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 0.3 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.2 | 0.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 2.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.5 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 1.4 | GO:1901750 | peptide modification(GO:0031179) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.2 | 1.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 1.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.5 | GO:0016598 | protein arginylation(GO:0016598) |
0.2 | 1.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.2 | 2.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 2.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 1.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 1.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 1.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.8 | GO:0070295 | glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.2 | 1.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 2.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 1.0 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 0.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.3 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.2 | 0.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 2.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.8 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 6.0 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.2 | 1.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 6.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.2 | 1.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 2.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.3 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 0.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.2 | 0.8 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.5 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 6.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 3.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 1.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 2.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.3 | GO:2000373 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.2 | 0.6 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 12.0 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 1.6 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.1 | 0.9 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0035787 | cell migration involved in kidney development(GO:0035787) |
0.1 | 1.9 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 1.3 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.1 | 0.3 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 1.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.3 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.4 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.1 | 0.6 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 3.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 2.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.7 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.1 | 4.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 3.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 1.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.7 | GO:2000698 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 1.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 1.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 1.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 1.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.8 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 1.6 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 0.4 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.7 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 2.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.7 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 9.2 | GO:0017148 | negative regulation of translation(GO:0017148) |
0.1 | 1.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.3 | GO:1902400 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.1 | 0.4 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.1 | 3.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 1.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 1.0 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 1.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.5 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.1 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.8 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 1.0 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.1 | 1.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 1.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 1.9 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.1 | 2.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 2.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.5 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 5.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 5.1 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 1.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 1.4 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 2.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.4 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.5 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.4 | GO:0036088 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.1 | 0.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 1.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 1.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 1.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 9.7 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 1.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 2.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 1.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.5 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 3.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.1 | 1.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.1 | 0.4 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.5 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.1 | 0.2 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 1.6 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 1.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.1 | 0.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 1.8 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.6 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.1 | 1.2 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.7 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 1.9 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 | 1.8 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.1 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.1 | 0.5 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.8 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 2.7 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.3 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.4 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.3 | GO:1990091 | sodium-dependent self proteolysis(GO:1990091) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 2.6 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.1 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.1 | 0.6 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.1 | 2.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 1.9 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 2.4 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 1.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 2.4 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 1.6 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 0.5 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.4 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.3 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.1 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.2 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) protein localization to bicellular tight junction(GO:1902396) |
0.1 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.7 | GO:0071231 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.1 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.2 | GO:0035934 | corticosterone secretion(GO:0035934) |
0.1 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.4 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 1.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 1.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 0.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 4.9 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 2.1 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 1.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 1.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 3.6 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.5 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
0.1 | 0.4 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.1 | 0.9 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.1 | 0.2 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.1 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 1.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.4 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 1.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.8 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.1 | 3.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.6 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 1.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 6.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.8 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.2 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.3 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 | 1.4 | GO:0048524 | positive regulation of viral process(GO:0048524) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.5 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.4 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 2.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.3 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 1.0 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 1.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.0 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 2.0 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 0.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.3 | GO:0003094 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.2 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.3 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.0 | 0.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.1 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.0 | 0.1 | GO:0015881 | creatine transport(GO:0015881) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.0 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.0 | 0.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.1 | GO:1990751 | regulation of Schwann cell chemotaxis(GO:1904266) positive regulation of Schwann cell chemotaxis(GO:1904268) Schwann cell chemotaxis(GO:1990751) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.0 | 0.1 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
0.0 | 0.3 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.1 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.0 | 0.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
0.0 | 0.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.0 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.1 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 11.9 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
3.5 | 24.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
3.0 | 12.2 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
2.1 | 12.6 | GO:0031523 | Myb complex(GO:0031523) |
1.9 | 11.3 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
1.7 | 18.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.5 | 6.2 | GO:0001740 | Barr body(GO:0001740) |
1.5 | 4.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.5 | 8.9 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
1.4 | 11.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.4 | 5.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
1.4 | 1.4 | GO:0097433 | dense body(GO:0097433) |
1.3 | 4.0 | GO:0034455 | t-UTP complex(GO:0034455) |
1.3 | 4.0 | GO:1902560 | GMP reductase complex(GO:1902560) |
1.2 | 7.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.2 | 9.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.2 | 12.2 | GO:0042382 | paraspeckles(GO:0042382) |
1.2 | 4.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.2 | 1.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.2 | 3.5 | GO:0000811 | GINS complex(GO:0000811) |
1.2 | 2.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.2 | 3.5 | GO:0043614 | multi-eIF complex(GO:0043614) |
1.1 | 3.4 | GO:1990879 | CST complex(GO:1990879) |
1.1 | 13.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.1 | 5.3 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
1.0 | 9.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.0 | 6.1 | GO:0001652 | granular component(GO:0001652) |
1.0 | 4.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.0 | 7.1 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 4.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
1.0 | 6.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.0 | 2.9 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
1.0 | 8.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.9 | 2.8 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.9 | 16.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.9 | 0.9 | GO:0019034 | viral replication complex(GO:0019034) |
0.9 | 11.1 | GO:0000796 | condensin complex(GO:0000796) |
0.9 | 11.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.9 | 11.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.9 | 20.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.9 | 6.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.9 | 9.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.8 | 12.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.8 | 2.5 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.8 | 8.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.8 | 2.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.8 | 3.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.8 | 3.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.8 | 3.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.8 | 5.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 15.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.7 | 3.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.7 | 8.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.7 | 2.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 5.2 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.7 | 0.7 | GO:0000805 | X chromosome(GO:0000805) |
0.7 | 6.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 15.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.7 | 8.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.7 | 2.1 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.7 | 2.1 | GO:1990031 | pinceau fiber(GO:1990031) |
0.7 | 4.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.7 | 2.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.7 | 3.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 2.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 3.9 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 2.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 11.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.7 | 3.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.6 | 3.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 7.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 2.4 | GO:0071920 | cleavage body(GO:0071920) |
0.6 | 11.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 1.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.6 | 5.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.6 | 8.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 10.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.6 | 45.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.6 | 2.9 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.6 | 8.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 2.9 | GO:0035363 | histone locus body(GO:0035363) |
0.6 | 4.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.6 | 1.7 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.6 | 5.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.5 | 3.8 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 5.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 3.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 3.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 2.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 2.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 1.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.5 | 1.6 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.5 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 1.5 | GO:0034359 | mature chylomicron(GO:0034359) |
0.5 | 1.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.5 | 2.0 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.5 | 6.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 5.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 1.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 2.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.5 | 0.9 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.5 | 2.8 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.5 | 1.9 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.5 | 24.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 1.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 3.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 6.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 36.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 4.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.4 | 1.3 | GO:0044308 | axonal spine(GO:0044308) |
0.4 | 1.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 3.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 3.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.4 | 6.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.3 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.4 | 4.7 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 4.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 6.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 2.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 5.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 3.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 1.2 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.4 | 2.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 3.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 0.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.4 | 3.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 1.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 9.7 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 5.8 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 5.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 3.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.4 | 3.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 1.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 18.2 | GO:0002102 | podosome(GO:0002102) |
0.4 | 2.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 4.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.4 | 1.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 5.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 4.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 2.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.4 | 5.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 12.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 5.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 2.5 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 1.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 5.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 1.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 1.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 1.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.3 | 1.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 2.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 1.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 2.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 3.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 4.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.3 | 5.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 1.0 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.3 | 2.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 2.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.3 | 0.9 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 1.2 | GO:1990032 | parallel fiber(GO:1990032) |
0.3 | 7.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 7.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 1.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 5.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 11.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 3.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 1.5 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 0.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 1.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 2.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 30.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 18.4 | GO:0005844 | polysome(GO:0005844) |
0.3 | 34.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 4.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 1.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 3.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.3 | 0.6 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 4.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 3.6 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 4.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 5.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 2.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 0.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 3.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 8.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 1.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.3 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 0.3 | GO:0090537 | CERF complex(GO:0090537) |
0.3 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 1.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 0.8 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 1.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 5.5 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 1.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.3 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 4.9 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 2.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 2.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.2 | GO:0044753 | amphisome(GO:0044753) |
0.2 | 18.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 6.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 4.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 6.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 2.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 24.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 5.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.9 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 3.4 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 2.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 4.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.7 | GO:0043291 | RAVE complex(GO:0043291) |
0.2 | 1.6 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 25.1 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 4.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 2.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 1.1 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 25.5 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 8.4 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 2.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 3.5 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.2 | 10.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 2.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 3.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 1.0 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.2 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 2.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 2.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 60.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 1.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.4 | GO:0070187 | telosome(GO:0070187) |
0.2 | 4.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 1.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 3.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.5 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.2 | 1.0 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 18.8 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 1.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 2.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 2.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 7.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 12.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 4.8 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 4.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 0.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 0.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 7.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 1.8 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 1.5 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 11.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 9.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 5.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 2.6 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 2.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 3.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 2.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 4.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 24.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 2.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 2.7 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 1.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 1.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 8.8 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.3 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.1 | 13.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 1.6 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 1.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 6.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 3.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 1.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 3.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 2.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 5.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0043512 | inhibin A complex(GO:0043512) |
0.1 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 3.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.9 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.3 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 1.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 1.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 2.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 1.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 10.5 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.7 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.8 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 3.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 4.6 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 4.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 1.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 4.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 8.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.1 | GO:0070992 | translation initiation complex(GO:0070992) |
0.1 | 2.7 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 4.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 1.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 36.2 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 1.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 16.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 1.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.1 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
0.0 | 1.2 | GO:0005819 | spindle(GO:0005819) |
0.0 | 6.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.0 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 4.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 1.2 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 17.5 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 11.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 1.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 0.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 3.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 1.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.3 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
2.6 | 10.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
2.6 | 7.7 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
2.5 | 7.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.9 | 5.8 | GO:0098808 | mRNA cap binding(GO:0098808) |
1.9 | 11.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.9 | 11.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.9 | 11.3 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
1.8 | 7.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.7 | 5.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.6 | 8.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.6 | 1.6 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
1.6 | 9.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.4 | 9.8 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.4 | 13.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.4 | 5.5 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
1.3 | 4.0 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
1.2 | 3.7 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
1.2 | 3.7 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
1.2 | 3.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.2 | 2.4 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
1.2 | 3.5 | GO:0001729 | ceramide kinase activity(GO:0001729) |
1.2 | 3.5 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
1.2 | 1.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.2 | 4.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.1 | 3.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.1 | 3.4 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
1.1 | 1.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.1 | 3.4 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.1 | 10.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.1 | 15.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.0 | 3.1 | GO:0019202 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
1.0 | 4.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.0 | 3.0 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.0 | 3.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.9 | 15.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.9 | 2.8 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.9 | 2.8 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
0.9 | 3.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.9 | 2.7 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.9 | 14.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.9 | 8.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 5.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.9 | 0.9 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.9 | 34.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.9 | 2.6 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.9 | 2.6 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.8 | 7.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 5.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.8 | 3.3 | GO:0072354 | histone kinase activity (H3-T3 specific)(GO:0072354) |
0.8 | 11.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.8 | 8.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 6.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.8 | 7.3 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.8 | 0.8 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.8 | 3.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.8 | 6.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.8 | 3.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.8 | 4.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.8 | 4.6 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.8 | 8.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.7 | 9.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 6.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.7 | 3.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.7 | 13.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.7 | 3.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.7 | 2.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.7 | 1.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 4.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.7 | 12.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.7 | 2.8 | GO:0070976 | TIR domain binding(GO:0070976) |
0.7 | 2.1 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
0.7 | 31.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.7 | 2.1 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.7 | 8.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.7 | 2.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.7 | 2.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.7 | 4.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.7 | 2.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.7 | 7.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 3.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.7 | 3.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.6 | 3.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.6 | 6.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 5.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.6 | 6.4 | GO:0043559 | insulin binding(GO:0043559) |
0.6 | 21.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.6 | 1.9 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.6 | 18.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.6 | 0.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 1.9 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.6 | 1.8 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.6 | 4.9 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 0.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.6 | 9.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.6 | 0.6 | GO:0070540 | stearic acid binding(GO:0070540) |
0.6 | 4.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.6 | 3.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.6 | 5.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 4.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.6 | 1.8 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.6 | 2.9 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.6 | 4.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.6 | 6.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 1.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.6 | 5.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 1.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.5 | 1.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.5 | 1.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.5 | 2.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 2.7 | GO:1990188 | euchromatin binding(GO:1990188) |
0.5 | 7.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 2.2 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.5 | 2.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.5 | 8.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 1.6 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
0.5 | 1.6 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.5 | 4.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.5 | 41.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 4.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 5.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 2.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 6.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.5 | 2.0 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.5 | 1.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 11.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 7.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.5 | 3.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 2.5 | GO:0097617 | annealing activity(GO:0097617) |
0.5 | 5.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.5 | 1.9 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.5 | 5.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 2.8 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.5 | 2.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 0.5 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.5 | 0.9 | GO:0043532 | angiostatin binding(GO:0043532) |
0.5 | 11.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 1.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.5 | 3.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 5.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.5 | 2.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 3.6 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.5 | 5.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.5 | 2.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 1.4 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.4 | 8.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 1.3 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.4 | 1.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 2.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.4 | 3.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 5.1 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 4.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 0.4 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.4 | 5.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.4 | 0.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 4.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 9.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 7.0 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 20.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 1.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 6.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 3.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 1.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 10.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 4.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 13.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 1.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.4 | 3.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 1.6 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 5.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 1.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.4 | 3.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 2.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 4.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 3.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 2.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.4 | 1.9 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.4 | 12.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.4 | 23.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 0.7 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.4 | 6.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 8.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 1.8 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.4 | 3.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 1.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 3.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 1.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.0 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.3 | 3.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 1.0 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.3 | 4.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 1.0 | GO:0005369 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.3 | 5.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 3.4 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 3.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 1.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 2.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 8.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 4.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 9.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 16.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 1.0 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.3 | 1.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 2.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 1.3 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.3 | 10.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 10.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 2.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 0.9 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.3 | 1.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 0.3 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.3 | 1.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 9.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.3 | 37.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 4.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 1.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 0.9 | GO:1990931 | oxidative DNA demethylase activity(GO:0035516) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
0.3 | 0.9 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.3 | 1.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.3 | 2.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 1.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 1.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 1.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.3 | 2.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 1.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.3 | 1.2 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.3 | 2.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.3 | 0.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.3 | 2.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 3.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 1.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 0.6 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.3 | 1.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.3 | 1.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.3 | 0.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 1.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 2.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.3 | 3.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 10.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 6.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 0.8 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 0.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.3 | 1.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.3 | 0.5 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.3 | 1.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 1.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 3.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 2.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 6.4 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 3.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 0.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 1.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 3.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 1.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 1.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 0.8 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 2.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 1.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 0.8 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 2.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 11.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.2 | 0.7 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.2 | 0.2 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 1.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 1.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.2 | 1.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 1.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.2 | 1.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.0 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 3.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 2.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 4.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.7 | GO:0002055 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
0.2 | 1.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 5.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 3.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 10.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.9 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.2 | 1.4 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.2 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 7.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.1 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.7 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
0.2 | 4.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.9 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.2 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 2.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 3.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.4 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.2 | 0.6 | GO:0032093 | SAM domain binding(GO:0032093) |
0.2 | 15.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.4 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.2 | 1.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.2 | 1.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 1.3 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 8.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.2 | 1.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 76.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 1.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 1.4 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 13.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 2.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.6 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.2 | 2.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 9.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 1.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 2.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 1.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 0.8 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.2 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.2 | 9.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 0.6 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.2 | 0.6 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 2.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 3.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.7 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 1.6 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 2.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 11.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 1.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 1.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 1.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 10.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.4 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 15.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 5.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.7 | GO:0004335 | galactokinase activity(GO:0004335) |
0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.3 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.2 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 1.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 5.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.2 | 3.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.5 | GO:0042497 | triacyl lipopeptide binding(GO:0042497) |
0.2 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 4.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 2.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 1.0 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 4.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 2.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 3.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 6.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 1.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 1.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.2 | 1.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.8 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 9.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.5 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 1.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 2.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 6.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 1.8 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.1 | 3.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.6 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
0.1 | 3.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 1.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 5.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 2.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 5.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.4 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.1 | 7.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 223.3 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 1.3 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.4 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 3.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 1.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.4 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.1 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 6.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 1.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.7 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 1.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 2.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 17.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 1.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 5.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.5 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 8.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 33.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.4 | GO:0051731 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 1.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 7.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 9.6 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 1.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.4 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.1 | 2.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 1.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 2.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.3 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 1.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.1 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 1.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 2.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 11.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 1.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 8.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 2.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 2.9 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.6 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.3 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 0.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.4 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 1.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.4 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 1.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.4 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.2 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 13.6 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 1.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 1.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 4.8 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 4.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 5.7 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
0.0 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 1.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.2 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 12.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.0 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.1 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.0 | 0.3 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 3.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.4 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.0 | 0.2 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 1.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 3.6 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 1.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.0 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.1 | GO:2001070 | glycerophosphocholine phosphodiesterase activity(GO:0047389) starch binding(GO:2001070) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 3.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 9.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 1.8 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.1 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.0 | 0.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 1.9 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 1.3 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 1.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 5.7 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.0 | GO:0070401 | NADP+ binding(GO:0070401) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.0 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 5.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.9 | 18.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.8 | 45.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.8 | 1.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 14.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 12.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.7 | 2.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 15.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 5.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.5 | 23.6 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 15.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 31.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 22.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 7.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 1.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 15.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 9.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 14.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 16.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 2.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 2.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 27.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 12.1 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 27.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 2.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 13.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 12.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 0.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 14.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 20.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 10.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 6.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 18.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 9.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 3.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 10.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 5.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 5.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 6.6 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 16.3 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 6.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 7.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 7.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 23.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 3.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 5.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 7.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 5.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 3.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 3.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 4.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 4.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 5.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 13.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 7.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 2.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 2.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 8.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 2.4 | PID ATM PATHWAY | ATM pathway |
0.2 | 9.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 1.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 5.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 3.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 4.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 3.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 13.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 5.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 2.2 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 6.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 8.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 2.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 3.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 10.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 6.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 3.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 5.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 6.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 3.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 3.4 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 7.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 22.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.3 | 1.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.2 | 3.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.1 | 34.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 19.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.9 | 11.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.8 | 65.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.8 | 5.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.8 | 0.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.8 | 10.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.7 | 8.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.7 | 1.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 0.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.7 | 5.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 14.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.6 | 1.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.6 | 26.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.6 | 18.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.6 | 7.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 14.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.6 | 5.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.5 | 6.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.5 | 6.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 48.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 14.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 0.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.5 | 11.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.5 | 4.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 7.2 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.5 | 9.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 9.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 27.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 6.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 29.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.5 | 7.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 33.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 3.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 3.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.4 | 4.9 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.4 | 3.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 13.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 7.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.4 | 13.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 52.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 8.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 7.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 11.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 5.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 11.6 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.4 | 8.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 4.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 1.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 10.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 9.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 7.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 4.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 14.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 7.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 10.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 9.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 12.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 20.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 0.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 7.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 4.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.3 | 11.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 4.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 4.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 5.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 2.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 3.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 6.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 9.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 9.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 3.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 7.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 1.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 7.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 2.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 9.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 4.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 9.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 3.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 19.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 17.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 6.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 6.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 3.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 6.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 6.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 1.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 3.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 4.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 3.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.9 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 5.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 4.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 1.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 1.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 3.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 9.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 0.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 1.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 3.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 3.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 3.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 4.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 11.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 6.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 1.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 11.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 4.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 5.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 1.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 2.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 27.0 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 3.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 4.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 2.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 1.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.6 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 2.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 1.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 1.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 5.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 3.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |